During the third quarter, Centene paid $229 million to transition from using the RxAdvance platform, according to an SEC filing.
During the third quarter, Centene paid $229 million to transition from using the RxAdvance platform, according to an SEC filing.
Copyright © 2024 | WordPress Theme by MH Themes